Equities Research Analysts’ upgrades for Monday, August 10th:
bioAffinity Technologies (NASDAQ:BIAF) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
Community Financial System (NYSE:CBU) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
CoreCivic (NYSE:CXW) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Farmers National Banc (NASDAQ:FMNB) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Hewlett Packard Enterprise (NYSE:HPE) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. They currently have $69.00 price target on the stock, down from their previous price target of $71.00.
Mativ (NYSE:MATV) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.
Mueller Water Products (NYSE:MWA) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
OraSure Technologies (NASDAQ:OSUR) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.
Everpure (NYSE:P) was upgraded by analysts at Susquehanna from a neutral rating to a positive rating. They currently have $120.00 price target on the stock, up from their previous price target of $85.00.
SAB Biotherapeutics (NASDAQ:SABS) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.
Sionna Therapeutics (NASDAQ:SION) was upgraded by analysts at Royal Bank Of Canada from an underperform rating to a sector perform rating. Royal Bank Of Canada currently has $5.00 target price on the stock.
Sandisk (NASDAQ:SNDK) was upgraded by analysts at Argus from a hold rating to a buy rating.
Turning Point Brands (NYSE:TPB) was upgraded by analysts at Wall Street Zen from a strong sell rating to a sell rating.
United Microelectronics (NYSE:UMC) was upgraded by analysts at Arete Research from a neutral rating to a buy rating.
Receive News & Ratings for bioAffinity Technologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
